Trinseo (NYSE: TSE), a global materials solutions provider and manufacturer of plastics, latex binders and synthetic rubber, will discuss ABS resins for medical applications at its upcoming webinar on July 11, 2018 at 10:00 am EST. This is part of Trinseo’s webinar series designed to educate the marketplace on polymer technology and related topics.
Customers, media, and the general public can register now.
Trinseo has been providing polymers to global medical device manufacturers for nearly three decades and supports single and multiple use medical devices, drug delivery systems, and medical equipment housings with material solutions. The company has seen an increase in the use of ABS for medical devices because of benefits including processability, aesthetics, colorability, and toughness as well as potential customer cost savings opportunities.
Trinseo offers its ABS under the MAGNUM™ ABS Resins brand. MAGNUM™ ABS is distinct due to its mass polymerization technology that results in an exceptionally white base color, low gel levels, and low residual Volatile Organic Compounds (VOCs).These properties are especially critical in the medical devices sector where purity, quality of color, and surface finish are key.
Besides MAGNUM™ ABS Resins, Trinseo offers CALIBRE™ Polycarbonate Resins, EMERGE™ Advanced Resins, and STYRON™ Polystyrene Resins. Trinseo has a full portfolio of medical grade resins that have been tested for biocompatibility according to ISO 10993.
Trinseo is committed to quality and customers’ compliancy requirements in the highly-regulated medical space. Its medical manufacturing and compounding facilities at Stade, Germany, Hsinchu, Taiwan, and in North America as well as related global functions are ISO 13485:2016 certified with the latest 2016 version focused on risk management and process validation.
About Trinseo
Trinseo (NYSE: TSE), a specialty material solutions provider, partners with companies to bring ideas to life in an imaginative, smart, and sustainability-focused manner by combining its premier expertise, forward-looking innovations and best-in-class materials to unlock value for companies and consumers.
From design to manufacturing, Trinseo taps into decades of experience in diverse material solutions to address customers’ unique challenges in a wide range of industries, including consumer goods, mobility, building and construction, and medical.
Trinseo’s approximately 3,400 employees bring endless creativity to reimagining the possibilities with clients all over the world from the company’s locations in North America, Europe, and Asia Pacific. Trinseo reported net sales of approximately $4.8 billion in 2021. Discover more by visiting www.trinseo.com and connecting with Trinseo on LinkedIn, Twitter, Facebook and WeChat.
Cautionary Note on Forward-Looking Statements
This press release may contain forward-looking statements including, without limitation, statements concerning plans, objectives, goals, projections, strategies, future events or performance, and underlying assumptions and other statements, which are not statements of historical facts or guarantees or assurances of future performance. Forward-looking statements may be identified by the use of words like "expect," "anticipate," "intend," "forecast," "outlook," "will," "may," "might," "see," "tend," "assume," "potential," "likely," "target," "plan," "contemplate," "seek," "attempt," "should," "could," "would" or expressions of similar meaning. Forward-looking statements reflect management’s evaluation of information currently available and are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Factors that might cause future results to differ from those expressed by the forward-looking statements include, but are not limited to, our ability to successfully execute our transformation strategy and business strategy; our ability to integrate acquired businesses; global supply chain volatility, increased costs or disruption in the supply of raw materials or increased costs for transportation of our products; the nature of investment opportunities presented to the Company from time to time; and those factors discussed in our Annual Report on Form 10-K, under Part I, Item 1A —"Risk Factors" and elsewhere in our other reports, filings and furnishings made with the U.S. Securities and Exchange Commission from time to time. As a result of these or other factors, our actual results may differ materially from those contemplated by the forward-looking statements. Therefore, we caution you against relying on any of these forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.